Basics Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis. IPO Date: February 1, 1998 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $32.98M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.81% Avg Daily Range (30 D): $0.04 | 3.43% Avg Daily Range (90 D): $0.04 | 2.99% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .23M Trade Size Avg Trade Size (Sh.): 322 Avg Trade Size (Sh.) (30 D): 322 Avg Trade Size (Sh.) (90 D): 268 Institutional Trades Total Inst.Trades: 186 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.46M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 30.67K         News Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research Mar 11, 2024 @ 10:15 PM Rockwell Medical (RMTI) Rises As Market Takes a Di... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.02 $-.04 $-.04 Diluted EPS $-.03 $-.04 $-.04 Revenue $ 97.73M $ 18.91M $ 24.67M Gross Profit $ 17.46M $ 3.04M $ 3.63M Net Income / Loss $ -.26M $ -1.52M $ -.76M Operating Income / Loss $ .57M $ -1.36M $ -.52M Cost of Revenue $ 80.27M $ 15.87M $ 21.03M Net Cash Flow $ 4.75M $ -4.27M $ 3.32M PE Ratio     Splits May 13, 2022:   1:11